Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and validation of an immune gene-set based Prognostic signature in ovarian cancer

27 Dec 2018

Abstract excerpt

BACKGROUND: Ovarian cancer (OV) is the most lethal gynecological cancer in women. We aim to develop a generalized, individualized immune prognostic signature that can stratify and predict overall survival for ovarian cancer. METHODS: The gene expression profiles of ovarian cancer tumor tissue samples were collected from 17 public cohorts, including 2777 cases totally. Single sample gene set enrichment (ssGSEA)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to interferon and immune responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30594555
DOI: 10.1016/j.ebiom.2018.12.054

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and validation of an immune gene-set based Prognostic signature in ovarian cancerPMID 30594555Read ↗

Development of a Multi-gene-based Immune Prognostic Signature in Ovarian CancerSemantic proximity Read ↗

Development and Verification of an Immune-Related Gene Pairs Prognostic Signature in Ovarian CancerSemantic proximity Read ↗

A Nine-Immune-Related Gene Prognostic Signature for Predicting Outcomes in High-Grade Serous Ovarian CancerSemantic proximity Read ↗

Single-sample gene set enrichment analysis reveals the clinical implications of immune-related genes in ovarian cancerSemantic proximity Read ↗

Development and verification of an immune‐related gene pairs prognostic signature in ovarian cancerSemantic proximity Read ↗

Development and Validation of a Five-immune Gene Pair Signature in Endometrial CarcinomaSemantic proximity Read ↗

Prognostic risk model of immune-related genes in ovarian cancerSemantic proximity Read ↗

Prognostic Risk Model of Immune-Related Genes In Ovarian CancerSemantic proximity Read ↗

Integrative network analysis identifies an immune-based prognostic signature as the determinant for the mesenchymal subtype in epithelial ovarian cancer.Semantic proximity Read ↗

Identification of an Immunologic gene signature in prediction the prognosis and therapeutic responses of ovarian cancerSemantic proximity Read ↗

Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancerSemantic proximity Read ↗

Classification of ovarian cancer associated with BRCA1 mutations, immune checkpoints, and tumor microenvironment based on immunogenomic profilingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.